Agilent Technologies Inc. has entered into a collaboration with the University of California, Davis, supporting Professor Marie Heffern's research into peptide and protein therapeutics. Through the Agilent Research Catalyst $(ARC)$ program, Agilent is providing financial support, advanced analytical instrumentation, and scientific expertise to accelerate innovation in peptide formulation science. This partnership aims to uncover new insights into metal-peptide interactions, potentially improving drug stability and performance for treatments related to diabetes and obesity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112485328) on November 12, 2025, and is solely responsible for the information contained therein.